Tutorials
Abiomed Inc logo

Abiomed Inc

$ 293.59 +2.66 (+0.91%) 08:08 PM EST
On watch
P/E:
61.94
P/B:
8.71
Market Cap:
$ 13.35B
Enterprise V:
$ 12.50B
Volume:
144.72K
Avg Vol (2M):
276.15K
Also Trade In:
Volume:
144.72K
Market Cap $:
13.35B
PE Ratio:
61.94
Avg Vol (2-Month):
276.15K
Enterprise Value $:
12.50B
PB Ratio:
8.71
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

Abiomed Inc
NAICS : 339112 SIC : 3841
22 Cherry Hill Drive, Danvers, MA, USA, 01923
Description
Abiomed Inc provides temporary mechanical circulatory support devices that are primarily used by interventional cardiologists and heart surgeons. The firm's products are used for patients in need of hemodynamic support before, during, or after angioplasty and heart surgery procedures. Abiomed receives the majority of revenue from its Impella product portfolio, which includes percutaneous micro heart pumps with integration motors and sensors and percutaneous catheter-based axial flow pumps. Abiomed generates the majority of its revenue in the United States.
Name Current Vs Industry Vs History
Cash-To-Debt No Debt
Equity-to-Asset 0.9
Interest Coverage No Debt
Piotroski F-Score 6/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 50.45
Distress
Grey
Safe
Beneish M-Score -2.71
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 56.66
9-Day RSI 58.26
14-Day RSI 58.96
6-1 Month Momentum % -13.08
12-1 Month Momentum % -20.46

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 7.53
Quick Ratio 6.86
Cash Ratio 6
Days Inventory 167.65
Days Sales Outstanding 31.02
Days Payable 59.58

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -0.3

Financials (Next Earnings Date:2022-10-28 Est.)

ABMD's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:ABMD

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 1,056.317
EPS (TTM) ($) 4.74
Beta 1.54
Volatility % 40.01
14-Day RSI 58.96
14-Day ATR ($) 9.828459
20-Day SMA ($) 286.4235
12-1 Month Momentum % -20.46
52-Week Range ($) 219.845 - 379.295
Shares Outstanding (Mil) 45.46

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 6
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Abiomed Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More